Regeneron Pharmaceuticals, Inc. (REGN) Discusses Factor XI Development Program and Clinical Data in Hematology Pipeline - Slideshow (NASDAQ:REGN) 2025-11-10

Group 1 - The article does not provide any specific content related to a company or industry [1]